{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:14:18Z","timestamp":1788185658778,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013298","name":"Sociedad Espa\u00f1ola de Reumatolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013298","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.medcli.2025.107313","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:43:37Z","timestamp":1768308217000},"page":"107313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Utility of systemic score as a prognosis marker and biologic treatment indication in adults with Still's disease"],"prefix":"10.1016","volume":"166","author":[{"given":"Ivette","family":"Casafont-Sol\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Narv\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Miquel","family":"Nolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Oliv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Holgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2025.107313_bib0085","first-page":"331","article-title":"Adult onset Still's disease: review of 41 cases","volume":"29","author":"Riera","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.medcli.2025.107313_bib0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/jcm14010285","article-title":"Non-classical complications of adult-onset Still's disease: a multicenter Spanish study","volume":"14","author":"Narv\u00e1ez","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.medcli.2025.107313_bib0095","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.medcli.2025.107313_bib0100","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.medcli.2025.107313_bib0105","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12916-016-0738-8","article-title":"Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers","volume":"14","author":"Ruscitti","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.medcli.2025.107313_bib0110","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3899\/jrheum.080365","article-title":"Clinical features and prognosis of adult-onset Still's disease: 61 cases from China","volume":"36","author":"Zeng","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.medcli.2025.107313_bib0115","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00296-011-1801-6","article-title":"Therapeutic responses and prognosis in adult-onset Still's disease","volume":"32","author":"Kim","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.medcli.2025.107313_bib0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/03009742.2024.2328439","article-title":"Adult-onset Still's disease: analysis of a monocentric cohort of patients","volume":"53","author":"Testa","year":"2024","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.medcli.2025.107313_bib0170","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0000000000000021","article-title":"Adult-onset Still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients","volume":"93","author":"Gerfaud-Valentin","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.medcli.2025.107313_bib0175","first-page":"28","article-title":"Clinical features and prognosis in 82 patients with adult-onset Still's disease","volume":"32","author":"Kim","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.medcli.2025.107313_bib0130","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3899\/jrheum.100247","article-title":"Clinical manifestations but not cytokine profiles differentiate adult onset Still's disease and sepsis","volume":"37","author":"Rau","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.medcli.2025.107313_bib0135","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/1744666X.2017.1332994","article-title":"Treatment of adult-onset Still's disease: up to date","volume":"13","author":"Yoo","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.medcli.2025.107313_bib0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10067-022-06340-7","article-title":"Performance of the modified systemic manifestation score for systemic juvenile idiopathic arthritis in adult-onset Still's disease","volume":"42","author":"Zhu","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.medcli.2025.107313_bib0150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/rheumatology\/keae295","article-title":"Efficacy and safety of biologic drugs in Still's disease: a systematic review and network meta-analysis of randomized controlled trials","volume":"64","author":"Kilic","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2025.107313_bib0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/14712598.2024.2307340","article-title":"The latest advances in the use of biological DMARDs to treat Still's disease","volume":"24","author":"Di Cola","year":"2024","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.medcli.2025.107313_bib0160","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.2024-1126","article-title":"Achievement and usefulness of intermediate treatment targets for Still disease proposed by the European Alliance of Associations for Rheumatology and the Paediatric Rheumatology European Society","author":"Tamai","year":"2025","journal-title":"J Rheumatol"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577532500541X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002577532500541X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:20:32Z","timestamp":1788182432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002577532500541X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S002577532500541X"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2025.107313","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of systemic score as a prognosis marker and biologic treatment indication in adults with Still's disease","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2025.107313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107313"}}